Viewing Study NCT00391560


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2025-12-27 @ 8:33 AM
Study NCT ID: NCT00391560
Status: COMPLETED
Last Update Posted: 2018-03-14
First Post: 2006-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia
Sponsor: AEterna Zentaris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module